Geron Corporation Stock News

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron to Announce Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference

Geron Corp. (GERN) shares closed today at 0.9% above its 52 week low of $1.16, giving the company a market cap of $376M. The stock is currently down 4.1% year-to-date, down 31.6% over the past 12 months, and down 49.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 27.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -55.6% The company's stock price performance over the past 12 months lags the peer average by 171.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron to Present at the H.C. Wainwright BioConnect Conference

Parametric Portfolio Associates LLC increased its stake in Geron Co. (NASDAQ:GERN) by 76.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,920 shares of the biopharmaceutical companys stock after buying an additional 72,571 shares during the quarter. Parametric Portfolio Associates []

Geron Corporation (NASDAQ:GERN) has a beta value of 1.06 and has seen 1.85 million shares traded in the last trading session. The company, currently valued at $415.51M, closed the last trade at $1.32 per share which meant it lost -$0.02 on the day or -1.49% during that session. The GERN stock price is -78.79% off Geron Corporation (GERN) Falls -1.49%, Causing Bears To Lose Read More »

The trading price of Geron Corporation (NASDAQ:GERN) closed lower on Friday, December 10, closing at $1.31, -2.96% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

Goldman Sachs Group Inc. boosted its stake in Geron Co. (NASDAQ:GERN) by 22.4% during the second quarter, Holdings Channel.com reports. The firm owned 286,621 shares of the biopharmaceutical companys stock after buying an additional 52,409 shares during the period. Goldman Sachs Group Inc.s holdings in Geron were worth $404,000 at the end of the most []

Metropolitan Life Insurance Co NY lifted its position in Geron Co. (NASDAQ:GERN) by 52,808.9% during the 2nd quarter, HoldingsChannel reports. The firm owned 41,798 shares of the biopharmaceutical companys stock after buying an additional 41,719 shares during the period. Metropolitan Life Insurance Co NYs holdings in Geron were worth $59,000 at the end of the []

In recent trading session, Geron Corporation (NASDAQ:GERN) saw 0.65 million shares changing hands at last check today with its beta currently measuring 1.06. Companys recent per share price level of $1.38 trading at $0.0 or -0.36% at last check today assigns it a market valuation of $424.13M. That most recent trading price of GERNs stock Geron Corporation (NASDAQ:GERN) Decline -0.36%, More Rally Possible Read More »